Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Intravitreal Implant vs Laser for DME (China Phase 3)
CTR20131189Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Nov 2015
- Modality
- Small Molecules, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of ozurdex in diabetic macular edema (DME), sponsored by AbbVie Inc.. Started Nov 2015; status: completed.
02
Drugs
ozurdex
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on CTR20131189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131189.